Abstract
Selective Laser Trabeculoplasty as a Replacement Therapy in Open Angle Glaucoma: A 3-Year Follow-Up Review
Highlights
Glaucoma is a progressive optic neuropathy which results with vision loss if left untreated [1]
Numerous clinical trials demonstrated that the only evidence-based treatment paradigm for glaucoma focuses on reducing Intra Ocular Pressure (IOP), which, if left untreated, has been associated with disease progression [2]
Important side effects caused by the preservant chemicals such as benzalchonium chloride or Poly Quad (PQ) on the ocular surface, which are widely used in glaucoma drops [6,7]
Summary
Glaucoma is a progressive optic neuropathy which results with vision loss if left untreated [1]. Numerous clinical trials demonstrated that the only evidence-based treatment paradigm for glaucoma focuses on reducing Intra Ocular Pressure (IOP), which, if left untreated, has been associated with disease progression [2]. Medical glaucoma therapy lasts for a lifetime and can reduce the life comfort of the patients due to the serious local and systemic side effects of the drugs. Topical β-blockers have been associated with systemic cardiac and respiratory adverse effects, which may limit their use in some patients [3]. Important side effects caused by the preservant chemicals such as benzalchonium chloride or Poly Quad (PQ) on the ocular surface, which are widely used in glaucoma drops [6,7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.